Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials

• Xin Mou,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Di-Yi Zhou,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Dan-Yang Zhou,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Jing-Ru Ma,

  Affiliation Zhejiang Chinese Medical University, City Road 548, Binjiang District, Hangzhou City, Zhejiang Province, 310053, China

  ⨯
• Ying-Hui Liu,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Hui-Ping Chen,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Yong-Bin Hu,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Cheng-Min Shou,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Jia-Wei Chen,

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯
• Wen-Hong Liu,

  Affiliation Zhejiang Chinese Medical University, City Road 548, Binjiang District, Hangzhou City, Zhejiang Province, 310053, China

  ⨯
• Guo-Ling Ma

  * E-mail: MAGuoling8888@163.com

  Affiliation Endocrinology Department, Hangzhou Red Cross Hospital, Hangzhou, 310003, China

  ⨯